S182 2 nd ESTRO Forum 2013 peripheral neuropathy (17.94 vs. 11.66, p=0.088) and lymphedema scores was observed (10 vs. 1.66, p=0.06). Twenty three patients who completed 6 months since IMRT, demonstrated improvement in physical and emotional function and significant decrease in symptom scales (p< 0.05) except insomnia score (p=0.276). On evaluation of cervix specific module, no difference was observed in functional scores as compared to baseline. However,an improvement in body image perception

more »

... 81.31 vs. 97.47, p=0.009) and significant decrease in peripheral neuropathy (p= 0.014) was observed. Though reduction in global QoL was observed, but scores remained higher than baseline scores.(70.28 vs. 65.21 ). Conclusions: Patients with cervical cancer have higher QOL scores at 6 months after completing adjuvant IMRT than at baseline. However this effect needs to be confirmed at further follow up and a larger cohort of patients undergoing IMRT.